Photomedicine Comprehensive Study by Application (Cancer, Infectious Disease, Inflammation, Dermatology, Others), End User (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2026

Photomedicine Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Photomedicine is the field of study in medicine which involves the research and use of photobiology related to health and disease. It has contributed to the clinical practice of various medical fields like dermatology, surgery, radiology, diagnostics, cardiology and anticancer therapy. In this, the light-based measurements of the skin are done which has the potential to improve another clinical diagnosis like skin cancer. The continuous research and development and government investment in this field have been increasing photomedicine technology. The photomedicine is widely used in laser surgeries.
This growth is primarily driven by Increasing Prevalence of Eye related Diseases and Growing Laser Surgeries is Increasing the Demand for Photomedicine.

Globally, a noticeable market trend is evident Increasing Photomedicine in Cancer Treatment . Major Players, such as THOR Photomedicine Ltd. (United Kingdom), Lumenis (Israel), Koninklijke Philips N.V. (Netherlands), Alma Lasers (United States), Colorado Skin & Vein (United States), AngioDynamics (United States), Syneron Medical Ltd. (United States), IRIDEX Corporation (United States), Erchonia Corporation (United States) and Deka Laser Technologies Inc. (Italy) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Market Drivers
  • Increasing Prevalence of Eye related Diseases
  • Growing Laser Surgeries is Increasing the Demand for Photomedicine

Market Trend
  • Increasing Photomedicine in Cancer Treatment
  • Growing Use of Photomedicine in Hair Removal Therapy

Restraints
  • Risk of Radiations and Negative Impact on Environment
  • Regulatory Guidelines Regarding Photomedicine

Opportunities
Continuous Research and Development In Photomedicine Technology and Increasing Awareness about Photomedicine
Challenges
Lack of Accuracy in Machines used for Photomedicine

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Photomedicine Study Sheds Light on
— The Photomedicine Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Photomedicine industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Photomedicine industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • Cancer
  • Infectious Disease
  • Inflammation
  • Dermatology
  • Others
By End User
  • Hospitals
  • Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Eye related Diseases
      • 3.2.2. Growing Laser Surgeries is Increasing the Demand for Photomedicine
    • 3.3. Market Challenges
      • 3.3.1. Lack of Accuracy in Machines used for Photomedicine
    • 3.4. Market Trends
      • 3.4.1. Increasing Photomedicine in Cancer Treatment
      • 3.4.2. Growing Use of Photomedicine in Hair Removal Therapy
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Photomedicine, by Application, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Photomedicine (Value)
      • 5.2.1. Global Photomedicine by: Application (Value)
        • 5.2.1.1. Cancer
        • 5.2.1.2. Infectious Disease
        • 5.2.1.3. Inflammation
        • 5.2.1.4. Dermatology
        • 5.2.1.5. Others
      • 5.2.2. Global Photomedicine by: End User (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Others
      • 5.2.3. Global Photomedicine Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Photomedicine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. THOR Photomedicine Ltd. (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Lumenis (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Koninklijke Philips N.V. (Netherlands)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Alma Lasers (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Colorado Skin & Vein (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AngioDynamics (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Syneron Medical Ltd. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. IRIDEX Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Erchonia Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Deka Laser Technologies Inc. (Italy)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Photomedicine Sale, by Application, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Photomedicine (Value)
      • 7.2.1. Global Photomedicine by: Application (Value)
        • 7.2.1.1. Cancer
        • 7.2.1.2. Infectious Disease
        • 7.2.1.3. Inflammation
        • 7.2.1.4. Dermatology
        • 7.2.1.5. Others
      • 7.2.2. Global Photomedicine by: End User (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Others
      • 7.2.3. Global Photomedicine Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Photomedicine: by Application(USD Million)
  • Table 2. Photomedicine Cancer , by Region USD Million (2015-2020)
  • Table 3. Photomedicine Infectious Disease , by Region USD Million (2015-2020)
  • Table 4. Photomedicine Inflammation , by Region USD Million (2015-2020)
  • Table 5. Photomedicine Dermatology , by Region USD Million (2015-2020)
  • Table 6. Photomedicine Others , by Region USD Million (2015-2020)
  • Table 7. Photomedicine: by End User(USD Million)
  • Table 8. Photomedicine Hospitals , by Region USD Million (2015-2020)
  • Table 9. Photomedicine Clinics , by Region USD Million (2015-2020)
  • Table 10. Photomedicine Others , by Region USD Million (2015-2020)
  • Table 11. South America Photomedicine, by Country USD Million (2015-2020)
  • Table 12. South America Photomedicine, by Application USD Million (2015-2020)
  • Table 13. South America Photomedicine, by End User USD Million (2015-2020)
  • Table 14. Brazil Photomedicine, by Application USD Million (2015-2020)
  • Table 15. Brazil Photomedicine, by End User USD Million (2015-2020)
  • Table 16. Argentina Photomedicine, by Application USD Million (2015-2020)
  • Table 17. Argentina Photomedicine, by End User USD Million (2015-2020)
  • Table 18. Rest of South America Photomedicine, by Application USD Million (2015-2020)
  • Table 19. Rest of South America Photomedicine, by End User USD Million (2015-2020)
  • Table 20. Asia Pacific Photomedicine, by Country USD Million (2015-2020)
  • Table 21. Asia Pacific Photomedicine, by Application USD Million (2015-2020)
  • Table 22. Asia Pacific Photomedicine, by End User USD Million (2015-2020)
  • Table 23. China Photomedicine, by Application USD Million (2015-2020)
  • Table 24. China Photomedicine, by End User USD Million (2015-2020)
  • Table 25. Japan Photomedicine, by Application USD Million (2015-2020)
  • Table 26. Japan Photomedicine, by End User USD Million (2015-2020)
  • Table 27. India Photomedicine, by Application USD Million (2015-2020)
  • Table 28. India Photomedicine, by End User USD Million (2015-2020)
  • Table 29. South Korea Photomedicine, by Application USD Million (2015-2020)
  • Table 30. South Korea Photomedicine, by End User USD Million (2015-2020)
  • Table 31. Taiwan Photomedicine, by Application USD Million (2015-2020)
  • Table 32. Taiwan Photomedicine, by End User USD Million (2015-2020)
  • Table 33. Australia Photomedicine, by Application USD Million (2015-2020)
  • Table 34. Australia Photomedicine, by End User USD Million (2015-2020)
  • Table 35. Rest of Asia-Pacific Photomedicine, by Application USD Million (2015-2020)
  • Table 36. Rest of Asia-Pacific Photomedicine, by End User USD Million (2015-2020)
  • Table 37. Europe Photomedicine, by Country USD Million (2015-2020)
  • Table 38. Europe Photomedicine, by Application USD Million (2015-2020)
  • Table 39. Europe Photomedicine, by End User USD Million (2015-2020)
  • Table 40. Germany Photomedicine, by Application USD Million (2015-2020)
  • Table 41. Germany Photomedicine, by End User USD Million (2015-2020)
  • Table 42. France Photomedicine, by Application USD Million (2015-2020)
  • Table 43. France Photomedicine, by End User USD Million (2015-2020)
  • Table 44. Italy Photomedicine, by Application USD Million (2015-2020)
  • Table 45. Italy Photomedicine, by End User USD Million (2015-2020)
  • Table 46. United Kingdom Photomedicine, by Application USD Million (2015-2020)
  • Table 47. United Kingdom Photomedicine, by End User USD Million (2015-2020)
  • Table 48. Netherlands Photomedicine, by Application USD Million (2015-2020)
  • Table 49. Netherlands Photomedicine, by End User USD Million (2015-2020)
  • Table 50. Rest of Europe Photomedicine, by Application USD Million (2015-2020)
  • Table 51. Rest of Europe Photomedicine, by End User USD Million (2015-2020)
  • Table 52. MEA Photomedicine, by Country USD Million (2015-2020)
  • Table 53. MEA Photomedicine, by Application USD Million (2015-2020)
  • Table 54. MEA Photomedicine, by End User USD Million (2015-2020)
  • Table 55. Middle East Photomedicine, by Application USD Million (2015-2020)
  • Table 56. Middle East Photomedicine, by End User USD Million (2015-2020)
  • Table 57. Africa Photomedicine, by Application USD Million (2015-2020)
  • Table 58. Africa Photomedicine, by End User USD Million (2015-2020)
  • Table 59. North America Photomedicine, by Country USD Million (2015-2020)
  • Table 60. North America Photomedicine, by Application USD Million (2015-2020)
  • Table 61. North America Photomedicine, by End User USD Million (2015-2020)
  • Table 62. United States Photomedicine, by Application USD Million (2015-2020)
  • Table 63. United States Photomedicine, by End User USD Million (2015-2020)
  • Table 64. Canada Photomedicine, by Application USD Million (2015-2020)
  • Table 65. Canada Photomedicine, by End User USD Million (2015-2020)
  • Table 66. Mexico Photomedicine, by Application USD Million (2015-2020)
  • Table 67. Mexico Photomedicine, by End User USD Million (2015-2020)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Photomedicine: by Application(USD Million)
  • Table 79. Photomedicine Cancer , by Region USD Million (2021-2026)
  • Table 80. Photomedicine Infectious Disease , by Region USD Million (2021-2026)
  • Table 81. Photomedicine Inflammation , by Region USD Million (2021-2026)
  • Table 82. Photomedicine Dermatology , by Region USD Million (2021-2026)
  • Table 83. Photomedicine Others , by Region USD Million (2021-2026)
  • Table 84. Photomedicine: by End User(USD Million)
  • Table 85. Photomedicine Hospitals , by Region USD Million (2021-2026)
  • Table 86. Photomedicine Clinics , by Region USD Million (2021-2026)
  • Table 87. Photomedicine Others , by Region USD Million (2021-2026)
  • Table 88. South America Photomedicine, by Country USD Million (2021-2026)
  • Table 89. South America Photomedicine, by Application USD Million (2021-2026)
  • Table 90. South America Photomedicine, by End User USD Million (2021-2026)
  • Table 91. Brazil Photomedicine, by Application USD Million (2021-2026)
  • Table 92. Brazil Photomedicine, by End User USD Million (2021-2026)
  • Table 93. Argentina Photomedicine, by Application USD Million (2021-2026)
  • Table 94. Argentina Photomedicine, by End User USD Million (2021-2026)
  • Table 95. Rest of South America Photomedicine, by Application USD Million (2021-2026)
  • Table 96. Rest of South America Photomedicine, by End User USD Million (2021-2026)
  • Table 97. Asia Pacific Photomedicine, by Country USD Million (2021-2026)
  • Table 98. Asia Pacific Photomedicine, by Application USD Million (2021-2026)
  • Table 99. Asia Pacific Photomedicine, by End User USD Million (2021-2026)
  • Table 100. China Photomedicine, by Application USD Million (2021-2026)
  • Table 101. China Photomedicine, by End User USD Million (2021-2026)
  • Table 102. Japan Photomedicine, by Application USD Million (2021-2026)
  • Table 103. Japan Photomedicine, by End User USD Million (2021-2026)
  • Table 104. India Photomedicine, by Application USD Million (2021-2026)
  • Table 105. India Photomedicine, by End User USD Million (2021-2026)
  • Table 106. South Korea Photomedicine, by Application USD Million (2021-2026)
  • Table 107. South Korea Photomedicine, by End User USD Million (2021-2026)
  • Table 108. Taiwan Photomedicine, by Application USD Million (2021-2026)
  • Table 109. Taiwan Photomedicine, by End User USD Million (2021-2026)
  • Table 110. Australia Photomedicine, by Application USD Million (2021-2026)
  • Table 111. Australia Photomedicine, by End User USD Million (2021-2026)
  • Table 112. Rest of Asia-Pacific Photomedicine, by Application USD Million (2021-2026)
  • Table 113. Rest of Asia-Pacific Photomedicine, by End User USD Million (2021-2026)
  • Table 114. Europe Photomedicine, by Country USD Million (2021-2026)
  • Table 115. Europe Photomedicine, by Application USD Million (2021-2026)
  • Table 116. Europe Photomedicine, by End User USD Million (2021-2026)
  • Table 117. Germany Photomedicine, by Application USD Million (2021-2026)
  • Table 118. Germany Photomedicine, by End User USD Million (2021-2026)
  • Table 119. France Photomedicine, by Application USD Million (2021-2026)
  • Table 120. France Photomedicine, by End User USD Million (2021-2026)
  • Table 121. Italy Photomedicine, by Application USD Million (2021-2026)
  • Table 122. Italy Photomedicine, by End User USD Million (2021-2026)
  • Table 123. United Kingdom Photomedicine, by Application USD Million (2021-2026)
  • Table 124. United Kingdom Photomedicine, by End User USD Million (2021-2026)
  • Table 125. Netherlands Photomedicine, by Application USD Million (2021-2026)
  • Table 126. Netherlands Photomedicine, by End User USD Million (2021-2026)
  • Table 127. Rest of Europe Photomedicine, by Application USD Million (2021-2026)
  • Table 128. Rest of Europe Photomedicine, by End User USD Million (2021-2026)
  • Table 129. MEA Photomedicine, by Country USD Million (2021-2026)
  • Table 130. MEA Photomedicine, by Application USD Million (2021-2026)
  • Table 131. MEA Photomedicine, by End User USD Million (2021-2026)
  • Table 132. Middle East Photomedicine, by Application USD Million (2021-2026)
  • Table 133. Middle East Photomedicine, by End User USD Million (2021-2026)
  • Table 134. Africa Photomedicine, by Application USD Million (2021-2026)
  • Table 135. Africa Photomedicine, by End User USD Million (2021-2026)
  • Table 136. North America Photomedicine, by Country USD Million (2021-2026)
  • Table 137. North America Photomedicine, by Application USD Million (2021-2026)
  • Table 138. North America Photomedicine, by End User USD Million (2021-2026)
  • Table 139. United States Photomedicine, by Application USD Million (2021-2026)
  • Table 140. United States Photomedicine, by End User USD Million (2021-2026)
  • Table 141. Canada Photomedicine, by Application USD Million (2021-2026)
  • Table 142. Canada Photomedicine, by End User USD Million (2021-2026)
  • Table 143. Mexico Photomedicine, by Application USD Million (2021-2026)
  • Table 144. Mexico Photomedicine, by End User USD Million (2021-2026)
  • Table 145. Research Programs/Design for This Report
  • Table 146. Key Data Information from Secondary Sources
  • Table 147. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Photomedicine: by Application USD Million (2015-2020)
  • Figure 5. Global Photomedicine: by End User USD Million (2015-2020)
  • Figure 6. South America Photomedicine Share (%), by Country
  • Figure 7. Asia Pacific Photomedicine Share (%), by Country
  • Figure 8. Europe Photomedicine Share (%), by Country
  • Figure 9. MEA Photomedicine Share (%), by Country
  • Figure 10. North America Photomedicine Share (%), by Country
  • Figure 11. Global Photomedicine share by Players 2020 (%)
  • Figure 12. Global Photomedicine share by Players (Top 3) 2020(%)
  • Figure 13. Global Photomedicine share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. THOR Photomedicine Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 16. THOR Photomedicine Ltd. (United Kingdom) Revenue: by Geography 2020
  • Figure 17. Lumenis (Israel) Revenue, Net Income and Gross profit
  • Figure 18. Lumenis (Israel) Revenue: by Geography 2020
  • Figure 19. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 20. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2020
  • Figure 21. Alma Lasers (United States) Revenue, Net Income and Gross profit
  • Figure 22. Alma Lasers (United States) Revenue: by Geography 2020
  • Figure 23. Colorado Skin & Vein (United States) Revenue, Net Income and Gross profit
  • Figure 24. Colorado Skin & Vein (United States) Revenue: by Geography 2020
  • Figure 25. AngioDynamics (United States) Revenue, Net Income and Gross profit
  • Figure 26. AngioDynamics (United States) Revenue: by Geography 2020
  • Figure 27. Syneron Medical Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Syneron Medical Ltd. (United States) Revenue: by Geography 2020
  • Figure 29. IRIDEX Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. IRIDEX Corporation (United States) Revenue: by Geography 2020
  • Figure 31. Erchonia Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Erchonia Corporation (United States) Revenue: by Geography 2020
  • Figure 33. Deka Laser Technologies Inc. (Italy) Revenue, Net Income and Gross profit
  • Figure 34. Deka Laser Technologies Inc. (Italy) Revenue: by Geography 2020
  • Figure 35. Global Photomedicine: by Application USD Million (2021-2026)
  • Figure 36. Global Photomedicine: by End User USD Million (2021-2026)
  • Figure 37. South America Photomedicine Share (%), by Country
  • Figure 38. Asia Pacific Photomedicine Share (%), by Country
  • Figure 39. Europe Photomedicine Share (%), by Country
  • Figure 40. MEA Photomedicine Share (%), by Country
  • Figure 41. North America Photomedicine Share (%), by Country
List of companies from research coverage that are profiled in the study
  • THOR Photomedicine Ltd. (United Kingdom)
  • Lumenis (Israel)
  • Koninklijke Philips N.V. (Netherlands)
  • Alma Lasers (United States)
  • Colorado Skin & Vein (United States)
  • AngioDynamics (United States)
  • Syneron Medical Ltd. (United States)
  • IRIDEX Corporation (United States)
  • Erchonia Corporation (United States)
  • Deka Laser Technologies Inc. (Italy)
Select User Access Type

Key Highlights of Report


Jan 2022 212 Pages 87 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Photomedicine market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Photomedicine market are THOR Photomedicine Ltd. (United Kingdom), Lumenis (Israel), Koninklijke Philips N.V. (Netherlands), Alma Lasers (United States), Colorado Skin & Vein (United States), AngioDynamics (United States), Syneron Medical Ltd. (United States), IRIDEX Corporation (United States), Erchonia Corporation (United States) and Deka Laser Technologies Inc. (Italy), to name a few.

Know More About Global Photomedicine Report?